Dr. Timeka Russell is an accomplished professional with a strong background in business and pharmacy management, specializing in operations leadership, cost control, and continuous process improvement. As the Senior Director of the Pharmacy Enterprise at New York-Presbyterian Health System, she oversees Pharmacy Billing and Finance, 340B Operations, Inventory and Procurement, $73M in inventory management across 12 hospitals and manages a total of $600M in annual pharmacy spend. With more than 15 years of experience in healthcare, Dr. Russell has demonstrated dynamic leadership, driving patient experience, increasing revenue, and promoting growth and expansion.

Dr. Russell’s expertise spans various areas, including supply chain, regulatory compliance, budgeting, internal audits, and pharmacy inventory management contracts. She is renowned as an expert in the 340B Federal Drug Pricing Program, making significant contributions to reducing costs and total pharmacy spend while streamlining efficiency and improving operations. She holds notable achievements in inventory consolidation, expanding pharmaceutical purchasing power, and enhancing drug tracking and tracing effectiveness.

In her career history, Dr. Russell served as Pharmacy Business Director at Inova Health System, where she managed drug procurement operations and the 340B Program. She successfully initiated 340B Program expansion, leading to $41M in total savings, and implemented Lean processes, improving compliance by 34% and streamlining reporting. At Rockford Health System, she held the role of Pharmacy Business Coordinator and 340B Program Manager.

Dr. Russell is a distinguished education achiever with a Doctorate in Health Administration from the University of Phoenix, a Master of Business Administration from Rockford College, and a Bachelor of Science in Business Administration. Additionally, Dr. Russell is certified as a Professional Coder, ICD-10 Specialist, and 340B Evangeline. Her publications, including “A Leadership Perspective on the 340B Healthcare Program: A Descriptive Case Study,” demonstrate her commitment to advancing the healthcare industry. Dr. She recently graduated from Harvard in June, 2024 and was a part of the Harvard Business Analytics 2 year program.

Russell’s memberships in esteemed organizations, such as the American College of Healthcare Executives and the Association for the Advancement of Artificial Intelligence, reflect her dedication to professional development and ongoing contributions to healthcare excellence.

• Character: Dr. Timeka Russell is an accomplished and driven professional with a strong background in business and pharmacy management, known for her dynamic leadership and commitment to excellence in healthcare.

• Knowledge: With expertise in various areas, including supply chain, regulatory compliance, budgeting, and pharmacy inventory management contracts, Dr. Russell is also recognized as an expert in the 340B Federal Drug Pricing Program, making significant contributions to cost reduction and operational efficiency.

• Strategic: Dr. Russell’s strategic acumen is evident in her successful implementation of inventory consolidation, expansion of pharmaceutical purchasing power, and the initiation of drug tracking and tracing compliance measures.

• Communication: Dr. Russell’s effective communication skills are reflected in her dynamic keynote presentations and her contributions to various publications and research, showcasing her ability to connect with diverse audiences and promote healthcare innovation.